SEC Filings

 
SEC Filings
Date Filing Description View
Oct 5, 2004 424B4 prospectus filed pursuant to rule 424 HTML PDF XLS
1.1 MB
Add to Briefcase
Oct 5, 2004 S-1MEF registration statement HTML PDF XLS
46.4 KB
Add to Briefcase
Oct 4, 2004 3 glaxosmithkline plc HTML PDF XLS
31.9 KB
Add to Briefcase
Oct 4, 2004 3 kitt michael HTML PDF XLS
34.0 KB
Add to Briefcase
Oct 4, 2004 3 vagelos p roy HTML PDF XLS
31.9 KB
Add to Briefcase
Oct 4, 2004 3 drazan jeffrey m HTML PDF XLS
31.0 KB
Add to Briefcase
Oct 4, 2004 3 levine arnold j HTML PDF XLS
29.3 KB
Add to Briefcase
Oct 4, 2004 3 loewenthal ronn HTML PDF XLS
30.7 KB
Add to Briefcase
Oct 4, 2004 3 mullen michael HTML PDF XLS
30.6 KB
Add to Briefcase
Oct 4, 2004 3 waltrip william h HTML PDF XLS
30.0 KB
Add to Briefcase
FirstPrevious
...
116
NextLast
= add PDF file to Briefcase

Innoviva NASDAQ: INVA

$13.06 0.09 (0.69%) 11/17/17 4:00 PM ET Refresh Quote

Data provided by Nasdaq.
Minimum 15 minutes delayed.

Contact

Innoviva Investor Relations & Media
650.238.9640

For business development inquiries,
please contact bd@inva.com.